Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses

MLA

Rohan Diwanji, et al. “Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses.” Cancer Immunology Research, May 2023, pp. OF1-OF15. EBSCOhost, https://doi.org/10.1158/2326-6066.cir-22-0290.

APA

Rohan Diwanji, Neil A. O’Brien, Jiyoung E. Choi, Beverly Nguyen, Tyler Laszewski, Angelo L. Grauel, Zheng Yan, Xin Xu, Jincheng Wu, David A. Ruddy, Michelle Piquet, Marc R. Pelletier, Alexander Savchenko, LaSalette Charette, Vanessa Rodrik-Outmezguine, Jason Baum, John M. Millholland, Connie C. Wong, Anne-Marie Martin, … Pushpa Jayaraman. (2023). Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses. Cancer Immunology Research, OF1-OF15. https://doi.org/10.1158/2326-6066.cir-22-0290

Chicago

Rohan Diwanji, Neil A. O’Brien, Jiyoung E. Choi, Beverly Nguyen, Tyler Laszewski, Angelo L. Grauel, Zheng Yan, et al. 2023. “Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses.” Cancer Immunology Research, May, OF1-OF15. doi:10.1158/2326-6066.cir-22-0290.